dc.contributor.author | Yazar, T. | |
dc.contributor.author | Yazar, H.O. | |
dc.contributor.author | Aygün, A. | |
dc.contributor.author | Karabacak, V. | |
dc.contributor.author | Altunkaynak, Y. | |
dc.contributor.author | Kirbaş, D. | |
dc.date.accessioned | 2021-12-21T08:40:33Z | |
dc.date.available | 2021-12-21T08:40:33Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 15901874 | |
dc.identifier.uri | https://doi.org/10.1007/s10072-020-04598-w | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1064 | |
dc.description.abstract | Objective: In our study, the aim was to identify the serum uric acid levels, a marker of oxidative stress, according to migraine subtypes (aura/without aura and episodic/chronic migraine). Method: The study included 300 migraine patients and 150 healthy c | |
dc.language.iso | English | |
dc.publisher | Springer-Verlag Italia s.r.l. | |
dc.title | Evaluation of serum uric levels in migraine | |
dc.type | Article | |
dc.relation.journal | Neurological Sciences | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 705 | |
dc.identifier.endpage | 709 | |
dc.identifier.volume | 42 | |
dc.identifier.doi | 10.1007/s10072-020-04598-w | |
dc.relation.issue | 2 | |
dc.relation.volume | 42 | |